Can Triple Therapy Make CAR-T Last Longer?
DXY had the pleasure of interviewing Dr. Jay Spiegel at ASH 2025, where he shared key insights from a Phase II study exploring a triple-modality strategy to enhance CAR-T durability.
DXY had the pleasure of interviewing Dr. Jay Spiegel at ASH 2025, where he shared key insights from a Phase II study exploring a triple-modality strategy to enhance CAR-T durability.